The 42nd annual J.P. Morgan Healthcare Conference started with clear skies and overall optimism from investors. But with Jamie Dimon’s prediction of a recession in 2024 on Tuesday morning, the climate shifted to an on-again,...more
1/12/2024
/ Acquisitions ,
Asset Diversification ,
Chapter 11 ,
Health Technology ,
Healthcare ,
Home Health Care ,
Hospice ,
Initial Public Offering (IPO) ,
Investors ,
JPMorgan Chase ,
Medicaid ,
Mental Health ,
Mergers ,
Pharmaceutical Industry ,
Reimbursements ,
Takeovers ,
Value-Based Care
W ith various headwinds resulting in down volume in 2023, buyers and sellers alike find themselves asking whether 2024 will see a rebound in deal activity. As we begin 2024, we have highlighted the issues and trends that...more
1/9/2024
/ Acquisitions ,
Artificial Intelligence ,
Corporate Transparency Act ,
Department of Justice (DOJ) ,
Diversity ,
Equity Markets ,
FinCEN ,
Funding ,
Healthcare ,
Investment ,
Investors ,
Mergers ,
Non-Compete Agreements ,
Pharmaceutical Industry ,
Popular ,
Privacy Laws ,
Private Equity ,
Reporting Requirements ,
Restrictive Covenants ,
Risk Management ,
Safe Harbors ,
Section 340B ,
Self-Disclosure Requirements ,
Value-Based Care
Physician practice management (PPM) platforms have been a staple for over a decade in their current form and are considered a mainstay of private equity’s investment in healthcare. PPMs have a number of unique transaction...more
4/13/2023
/ Buyers ,
Comment Period ,
Employee Retention ,
Federal Trade Commission (FTC) ,
Health Care Providers ,
Healthcare ,
Investment ,
Investors ,
Non-Compete Agreements ,
Physicians ,
Private Equity ,
Sellers
Even the threat of an unprecedented atmospheric river storm could not stop the tried and true from attending the 41st annual J.P. Morgan Healthcare Conference. With a break of sunshine on Monday, we found ourselves asking,...more
1/13/2023
/ Acquisitions ,
Debt ,
Federal Trade Commission (FTC) ,
Funding ,
Healthcare ,
Investment ,
Investors ,
Mergers ,
Non-Compete Agreements ,
Private Equity ,
Proposed Rules
As we kick off 2023, we are optimistic that the healthcare private equity (PE) market will be resilient despite various headwinds. As you think ahead, please consider the issues and trends summarized below that may be helpful...more
1/9/2023
/ Capital Markets ,
Cyber Attacks ,
Cybersecurity ,
Debt Market ,
Earn-Outs ,
Employee Retention ,
Environmental Social & Governance (ESG) ,
Health Care Providers ,
Healthcare ,
Healthcare Fraud ,
Investment ,
Investors ,
Minority Equity Investments ,
New Legislation ,
New Rules ,
Non-Compete Agreements ,
Physicians ,
Private Equity ,
Proposed Regulation ,
Ransomware ,
Rollover Equity ,
Section 220 Request
Following a record-breaking first quarter, merger and acquisition (M&A) activity within the healthcare industry kept pace during the second quarter of 2021, showing no signs of slowing. Although the volume of deal activity...more
8/24/2021
/ Acquisitions ,
Ambulatory Surgery Centers ,
Buyers ,
Coronavirus/COVID-19 ,
Digital Health ,
Health Information Technologies ,
Hospice ,
Hospitals ,
Investors ,
Life Sciences ,
Managed Care Contracts ,
Mergers ,
Pharmaceutical Industry ,
Physicians ,
Private Equity ,
Private Equity Funds ,
Special Purpose Acquisition Companies (SPACs)
Bass, Berry & Sims recently presented the latest in its Dealmaker Perspectives series on the medical device industry. Ryan Thomas, Member of Bass, Berry & Sims and Co-Chair, Healthcare Private Equity Team, and Frank...more
For the fifth consecutive year, the Bass, Berry & Sims Healthcare Private Equity Team hosted BBS Connect, a forum to connect healthcare dealmakers during the annual J.P. Morgan Healthcare Conference.
Over three days –...more
The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19...more
12/7/2020
/ Accelerated Payments ,
Buyers ,
CARES Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Economic Injury Disaster Loans ,
Employee Retention ,
False Claims Act (FCA) ,
Families First Coronavirus Response Act (FFCRA) ,
Government Investigations ,
Indemnification ,
Loan Forgiveness ,
Main Street Lending Programs ,
Material Adverse Effects ,
Paycheck Protection Program (PPP) ,
Payroll Taxes ,
Private Equity ,
Provider Relief Fund ,
Representations and Warranties ,
SBA ,
Securities and Exchange Commission (SEC) ,
Sellers ,
SIGPR ,
Tax Credits ,
Tax Deferral
On October 2, the Small Business Administration (SBA) issued an important Procedural Notice clearing the way for dealmakers to begin closing M&A transactions involving targets with outstanding Paycheck Protection Program...more
With the much-anticipated release of the Small Business Administration (SBA) Interim Final Rule on affiliation under the Paycheck Protection Program (PPP) late on April 3, those waiting with bated breath for any clarification...more
While many healthcare-focused middle- and lower-middle market private equity firms and their portfolio companies continue to spend the bulk of their time addressing operational, cash flow and workforce issues related to...more
The recently declared global pandemic, COVID-19, has had a particularly acute impact on the healthcare industry and healthcare private equity investors. There are many issues affecting private healthcare companies on several...more
By all accounts, 2019 proved to be another year of significant investment by private equity firms in the physician practice space. Below we discuss 10 trends we observed as counsel on a number of these transactions during...more
1/22/2020
/ Acquisitions ,
Commercial Insurance Policies ,
Contract Negotiations ,
Contract Terms ,
Due Diligence ,
Health Care Providers ,
Hospitals ,
Indemnity Insurance ,
Mergers ,
Partnerships ,
Physicians ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Strategic Planning
Following the launch of several platforms in recent years, it seems that private equity’s interest in the fertility space is trending up again. Investment in this sector brings some unique issues that potential investors...more
11/13/2019
/ Anti-Kickback Statute ,
Clinical Laboratories ,
Consent ,
Discounts ,
Due Diligence ,
Fertility Treatments ,
Health Care Providers ,
Investors ,
Joint Venture ,
Partnerships ,
Patient Referrals ,
Physicians ,
Prescription Drugs ,
Private Equity ,
Private Equity Firms
In the wave of physician practice management transactions, urology is poised to be one of the next hot sectors. In addition to the issues to consider in connection with any physician practice transaction, below we discuss...more
6/26/2019
/ Anti-Kickback Statute ,
False Billing ,
False Claims Act (FCA) ,
Healthcare ,
Healthcare Fraud ,
Medical Devices ,
Pharmaceutical Industry ,
Physician-Owned Hospitals ,
Physicians ,
Private Equity ,
Safe Harbors ,
Stark Law ,
Value-Based Care
Spring cleaning season has arrived! This time of year serves as the perfect opportunity to revisit your portfolio company’s healthcare compliance. The complex and ever changing healthcare regulatory and enforcement...more